HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 387 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $487 | +44.5% | 9,295 | +12.1% | 0.01% | +50.0% |
| Q1 2024 | $337 | +29.1% | 8,294 | +17.3% | 0.00% | 0.0% |
| Q4 2023 | $261 | -10.9% | 7,069 | -7.8% | 0.00% | -20.0% |
| Q3 2023 | $293 | -99.9% | 7,663 | -0.1% | 0.01% | -37.5% |
| Q4 2022 | $436,000 | -99.8% | 7,668 | +16.3% | 0.01% | +60.0% |
| Q3 2022 | $261,000,000 | – | 6,591 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |